ArticleCureus2025
Consultant Psychiatrists as Chief Executive Officers (CEOs): Competencies and Challenges.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Effective medical leadership is critical to delivering high-quality healthcare, with evidence linking strong leadership to improved patient outcomes. This study explores the insights and experiences of consultant psychiatrists currently working as Chief Executive Officers (CEOs) of mental health organizations within the United Kingdom (UK), examining how their clinical training influenced their leadership capabilities. Methods This study is a qualitative study with brief closed-item descriptors. The study population was consultant psychiatrists in the United Kingdom serving as CEOs of mental health organizations, a census of n = 5, with n = 4 responses to the survey. A questionnaire was designed by the authors for the purpose of this study. The questionnaire consisted of five multiple-choice questions and five open-ended questions. The results were analysed using descriptive statistics and Braun and Clarke's thematic analysis. Results Of the four psychiatrist CEOs who took part in the study, all had over 20 years of psychiatric experience. Their duration of time as CEO varied, with 2/4 serving for one to three years, 1/4 for four to seven years, and 1/4 for over seven years. Of the aspects of psychiatric training most beneficial to the role of CEO, 4/4 felt that patient-centred care and analytical thinking were beneficial, and 3/4 felt that ethical decision-making, crisis management, empathy, and communication skills were beneficial. The participants highlighted clinical leadership and a deep understanding of human behaviour as major advantages of their medical background. However, challenges such as managing staff expectations, balancing clinical and administrative duties, time constraints, and emotional burnout were also reported. Conclusion Consultant psychiatrists possess transferable skills that align well with leadership roles, including CEO positions. Limitations of this study include the small sample size and the risk of identifiability of the consultant psychiatrist CEOs. This study did not require ethical approval as confirmed by the National Health Service (NHS)/Health Research Authority (HRA) decision tool. Participation in the study was voluntary, and responses were anonymised. While not all psychiatrists may aspire to such roles, targeted training and opportunities should be provided to support those interested in pursuing executive leadership in healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.